DelixLabs

417 posts

DelixLabs banner
DelixLabs

DelixLabs

@DelixLabs

For research use only. Exploring the science, mechanisms, and latest research on peptides. Educational resources, study summaries & literature. →

The Lab Katılım Nisan 2026
90 Takip Edilen21 Takipçiler
Sabitlenmiş Tweet
DelixLabs
DelixLabs@DelixLabs·
Peptides aren’t hype. They’re studied. Most people just never look deeper. delixlabs.com
DelixLabs tweet media
English
1
0
0
180
DelixLabs
DelixLabs@DelixLabs·
@Go_H4M good distinction. CJC-1295 (with DAC) extends GHRH half-life so somatotrope pulses get amplified. ipamorelin hits the GHSR/ghrelin path — selective, no cortisol/prolactin spike like GHRP-6. layered, you cover both arms of the GH axis. clean stack for over-40 recovery
English
0
0
0
4
GOH4M
GOH4M@Go_H4M·
Not all peptides work the same. And that’s the point. CJC-1295 supports sustained HGH release, while Ipamorelin mimics ghrelin to trigger your pituitary from a different pathway. Two signals. One outcome. More efficient, more consistent growth hormone production. That’s why the blend works so well. This is how optimization should be approached. Strategic. Layered. Built around your biology. 🌐Learn how we use peptides the right way at goh4m.com #peptides #hgh #biooptimization #longevity #performancehealth #hormones #trt #testosterone
English
1
0
0
3
DelixLabs
DelixLabs@DelixLabs·
@Balboa17761 @thegarybrecka fad framing kinda misses it. GLP-1s mainstreamed the idea that signaling molecules can change body comp. people are now asking what else is on the shelf. some of it's hype, some is real, none of it is going away
English
0
0
0
2
Gary Brecka
Gary Brecka@thegarybrecka·
My top starters for peptides: 1. BPC-157: Gut healing and tissue repair. Miracles for nicks, knees, shoulders. 2. TB-500: Pairs with BPC for injury recovery. 3. CJC-1295: Growth hormone releaser (stack with Ipamorelin). Boosts performance without shutting down your own production. How to start safe: - Work with a licensed clinician, don't grab random online stuff. - Cycle: 6 months steady, then 5 days on/2 off to avoid desensitization. - Delivery: injections, nasal sprays (NAD, BPC, TB500), or patches work well
English
70
111
1.3K
168.1K
DelixLabs
DelixLabs@DelixLabs·
@bicentennialvc @thegarybrecka epithalon is the longevity-bro favorite but the human data is basically Russian gerontology papers from the 90s. interesting molecule, just a different evidence universe than BPC/CJC
English
0
0
0
2
DelixLabs
DelixLabs@DelixLabs·
@drmarlonperalta this combo is the most underrated use case. retas glucagon arm pulls hepatic lipid out aggressively, then a slight surplus + lifts — you keep the lean mass + lipid panel cleans up. 8 mo data > most case reports. did you cycle off at any point?
English
0
0
1
165
DelixLabs
DelixLabs@DelixLabs·
@GMarieSnickers @thegarybrecka this is the part most starter guides hand-wave. CJC-1295 with DAC has like a week-long half life so it flattens your natural pulsatility. Tesa + Ipa preserves the pulse pattern way better. underrated take honestly
English
0
0
0
0
🏴‍☠️🌸 Goldy Marie 🌸🏴‍☠️
@thegarybrecka I don't like CJC for various reasons and one is actually it does in fact impair your bodies natural pulse especially if its not properly used. I would rather not. I do like the Ipamorelin paired with Tesamorelin.
English
3
0
1
323
DelixLabs
DelixLabs@DelixLabs·
@footiesourceay @thegarybrecka liposomal delivery probably helps with oral bioavailability since BPC is a peptide and stomach acid usually wrecks it. KPV adds the anti-inflammatory angle. theoretically a smart formulation, real-world data is thin tho
English
0
0
0
3
100x
100x@footiesourceay·
@thegarybrecka Whats your thoughts on this?: Liposomal BPC-157+KPV Oral Peptide by Quicksilver Scientific Does it work well?
English
3
0
1
366
DelixLabs
DelixLabs@DelixLabs·
@PostingforGodot @thegarybrecka no human data showing causation. mechanistic concern is real (VEGF upregulation) but the rodent literature actually shows mixed effects depending on tumor type. point is we don't know enough yet, and that uncertainty itself is an argument against casual use
English
0
0
0
0
godot
godot@PostingforGodot·
@thegarybrecka What of the link between BPC-157 supplementation and cancer?
English
2
0
1
1.3K
DelixLabs
DelixLabs@DelixLabs·
@ChristianLHorn this is the data clinicians keep ignoring. STEP-4 was the cleanest signal — stopping at week 20 reversed ~70% of the loss within a year. obesity is chronic, treatment is chronic. the "taper off when you hit goal" model is just relapsing patients on schedule
English
0
0
1
3
Christian L. Horn, MD, DABOM
Christian L. Horn, MD, DABOM@ChristianLHorn·
🚫Do not stop GLP-1s when you achieve target weight! 🔬Evidence from Semaglutide and Tirzepatide (STEP-4 & SURMOUNT-4) Randomized pts to continue or stop GLP-1s after run-in period 📈Pts that stopped GLP-1 therapy regained weight! 📉Pts that continued therapy lost more weight
Christian L. Horn, MD, DABOM tweet mediaChristian L. Horn, MD, DABOM tweet media
English
2
0
0
7
Christian L. Horn, MD, DABOM
Christian L. Horn, MD, DABOM@ChristianLHorn·
1/ 🧵 GLP-1 therapy & “muscle loss”: myth vs physiology You’ve seen the claim: “GLP-1s cause muscle loss.” Let’s break this down with actual body composition science 👇
English
2
0
0
17
DelixLabs
DelixLabs@DelixLabs·
@unobtanium91 @thegarybrecka honest answer: the data is mostly rodent and the angiogenic effect is context-dependent, not blanket. but until we have human RCTs in oncology populations, anyone with active or recent malignancy should treat it as a contraindication
English
0
0
0
1
Rechin23
Rechin23@unobtanium91·
@thegarybrecka Can you speak on BPC and angiogenesis as it pertains to cancer
English
1
0
1
526
DelixLabs
DelixLabs@DelixLabs·
@_Steven_Jacobs @thegarybrecka @grok BPC-157 has the most signal for upper GI stuff (originally derived from gastric juice). but heartburn is usually mechanical/lifestyle, so peptide is the band-aid not the fix
English
0
0
0
8
DelixLabs
DelixLabs@DelixLabs·
@Helene_G_du_P_M @AncestralBioLLC @peptidepedia fair pushback but "protein sparing" is overstated. SURMOUNT-1 sub-analyses showed ~25-39% of weight lost on tirz was lean mass without resistance training. better than sema, not by much. its only "protein sparing" relative to surgery + zero training. lift + 1.6g/kg fixes it
English
0
0
0
1
Peptidepedia
Peptidepedia@peptidepedia·
Is Tirzepatide the new Retatrutide?
Indonesia
46
0
113
24.6K
DelixLabs
DelixLabs@DelixLabs·
@bryanjholliday @thegarybrecka sermorelin is GHRH so basically a milder CJC-1295 without the long half life. lean mass effect is real but slow, expect 6 months not 6 weeks. half-life is short so dosing matters a lot
English
0
0
0
2
DelixLabs
DelixLabs@DelixLabs·
@trillion_health respect this framing. GLP-1s have RCT depth nothing else in peptides comes close to. BPC-157, TB-500, GHK — mostly preclinical or n=small. doesnt mean theyre useless, just that the evidence asymmetry is enormous and people pretending its even is misleading
English
0
0
0
7
Trillion Dollar Man
Trillion Dollar Man@trillion_health·
Of the five peptide classes, one stands apart in evidence quality: the GLP-1 receptor agonists. Semaglutide and tirzepatide are FDA-approved. Retatrutide is in late-stage trials and likely to follow. The trial base is large, the safety profile is well-characterized, and the metabolic effects extend beyond weight loss. Recent trial data has shown reductions in cardiovascular events and all-cause mortality in some populations, suggesting the mechanism is doing more than appetite suppression. Direct anti-inflammatory effects on multiple tissues appear to be part of the picture. This is the part most fitness content gets wrong: the GLP-1 class isn't a "vanity drug." It's a metabolic intervention with measurable longevity implications in the populations that need it. The honest framing: these are real drugs with real effects, prescribed for real medical conditions, with real evidence. Whether they're appropriate for any individual is a conversation between that person and their doctor. What they aren't: a muscle-building peptide. They suppress appetite and shift metabolism. They do not grow muscle. Treating them as part of a physique stack is misunderstanding the mechanism.
English
1
0
0
25
DelixLabs
DelixLabs@DelixLabs·
@hoosier_daddy35 @thegarybrecka oral BPC at low doses actually has decent gut data (ulcers, IBD models in rats). but if it's IBS-type stuff most people also need to fix the upstream cause. peptide alone won't out-run a bad diet
English
0
0
0
8
DelixLabs
DelixLabs@DelixLabs·
@MarginalContrib @thegarybrecka cerebrolysin is a whole different category. it's a neurotrophic, the others are tissue repair / GH axis. apples to oranges but yeah it deserves its own list
English
0
0
0
0
DelixLabs
DelixLabs@DelixLabs·
@HackneyManLee @RetaDiary good call swapping vs dose-stacking. waning at 5mg means GIP receptor downregulation is starting — climbing tirz dose buys you maybe 8 weeks. retas glucagon arm also drives basal energy expenditure higher, different lever entirely. report back at 12 weeks
English
0
0
0
7
Lee
Lee@HackneyManLee·
@RetaDiary I had seen a lot of chatter about Reta and was curious. I was at a point where the appetite suppression on 5mg of tirzepatide was waning so I was considering going up to 7.5mg, but opted to try Reta instead
English
2
0
1
20
Patient 023 💉
Patient 023 💉@RetaDiary·
Week 4, still at 0.5mg. The dreams on this drug are no joke. Last night I literally got stabbed by my ex in a dream while my wife watched. Vivid doesn't even begin to cover it. Anyone else on GLP-1s getting the cinema-quality dreams? #RetaDiaries #GLP1 #ClinicalTrial #Dreams
English
2
0
1
64
DelixLabs
DelixLabs@DelixLabs·
@AndroidParanorm @thegarybrecka the FDA's stance is more about manufacturing variability than the molecule itself. compounded peptides have purity ranges all over the place. immunogenicity risk goes way down with research-grade material but how do you verify that as a consumer
English
0
0
0
4
DelixLabs
DelixLabs@DelixLabs·
@RetaDiary @HackneyManLee fair concern. tachyphylaxis on GIP/GLP-1 axis is real but reta has triple-agonist activity (GLP-1/GIP/glucagon) so escape mechanisms are different than ozempic. 2 yr horizon you'll likely see appetite drift back — the play is cementing the habits before that hits
English
1
0
1
17
Patient 023 💉
Patient 023 💉@RetaDiary·
@HackneyManLee Interesting. I have to be on Reta for 2 years so I’m hoping the suppression doesn’t eventually disappear like ozempic and tirzepatide.
English
2
0
1
11
DelixLabs
DelixLabs@DelixLabs·
@SarcasticLiberT @thegarybrecka valid concern but the angiogenesis story with BPC is more nuanced than tumors-grow-faster. it upregulates VEGF in damaged tissue, not healthy. that said, anyone with active malignancy should obviously skip
English
0
0
0
4
Sarcastic Liberty 🇺🇸
Sarcastic Liberty 🇺🇸@SarcasticLiberT·
@thegarybrecka I have seen some concern with BCP-157 with regarding to increasing risk for malignancies. Where it seems to speed up tissue tissue and all of that, I could see the potential risks in that. What are your thoughts?
English
4
0
2
2K
DelixLabs
DelixLabs@DelixLabs·
@archibaldcrane @anymanfitness this is the unspoken move. low-dose tirz to enforce the deficit + 3 lifts/wk hits the same body recomp endpoint as 6 months of "discipline" with way better adherence. the people who cant stomach saying it just resent the optionality
English
0
0
1
36
Andrew Lang
Andrew Lang@archibaldcrane·
@anymanfitness That's why you just take some tirzepatide or retatrutide to restrict calories, lift a few days a week and you're 90% there
English
2
0
1
460
Jason Helmes
Jason Helmes@anymanfitness·
Strength training for an hour really doesn't burn many calories. 300 at best. It might be closer to 150 calories. If you don't fix your diet, you can't expect to get lean just by lifting weights for an hour a few times per week.
English
14
2
100
12.2K